Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 698

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 698
---
 addition to the direct contributions described above, Heritas Ltd. provided share -based incentives amounting to US$1,226,867 during the fiscal year ended June 30, 2024. This represents the fair value of equity instruments issued under the Parent Company’s share -based payment arrangements and is recognized in the Combined Income Statement under “General and Administrative Expenses”. The corresponding increase is recorded in the Share premium within equity. b)Loans: The Group has received financial support through long -termloans provided by its shareholders and other related parties. Below is a detailed breakdown of the composition of these loans:

| Lender           |     |  June 30, 
      2024 |     |  June 30, 
      2023 |
|:-----------------|:----|----------:|:----|----------:|
| Heritas Ltd.     |     |   642,699 |     |   303,500 |
| CIBIC            |     | 1,279,997 |     |   264,649 |
| Bioceres S.A.    |     |   738,312 |     |   561,808 |
| Total Borrowings |     | 2,661,008 |     | 1,129,957 |

| Lender           
 As of            
 June 30,         
 2024             |     | Date of    
 Loan       
 Agreement  
 As of      
 June 30,   
 2023       |     | Maturity   |     | Annual   
 Average  
 Interest 
 Rate     |     | Currency |     |     Nominal 
 Value As of 
    June 30, 
        2024 |     | Book Value |     |           |
|:-----------------|:----|:-----------|:----|:-----------|:----|:---------|:----|:---------|:----|------------:|:----|-----------:|:----|----------:|
| Heritas Ltd.(*)  |     | 01/6/2022  |     | 1/6/2028   |     | 6.5%     |     | US$      |     |     604,538 |     |    642,699 |     |   303,500 |
| CIBIC            |     | 01/17/2023 |     | 01/17/2028 |     | 6.5%     |     | US$